Global Pharmatech, Inc. (GBLP) Stock
Global Pharmatech, Inc. engages in the discovery, development, manufacturing, and marketing of proprietary drugs developed based on traditional Chinese medicine.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Global Pharmatech, Inc.
Global Pharmatech, Inc. engages in the discovery, development, manufacturing, and marketing of proprietary drugs developed based on traditional Chinese medicine. Its operations are based in the People's Republic of China with sales distribution in China, Singapore, Malaysia, Indonesia, and USA. The company was founded on June 26, 2001 and is headquartered in Hong Kong.
Global Pharmatech, Inc. is headquartered in HK.
Global Pharmatech, Inc. (GBLP) stock trades at $0.08 with a market capitalization of $33.25M. The stock is valued at a price-to-earnings (P/E) ratio of 800.90, price-to-book of -3671.26, price-to-sales of 63.82. Over the past 52 weeks the stock has ranged between $0.05 and $0.11, and currently trades 27.3% below its 52-week high.
On profitability, Global Pharmatech, Inc. generates a return on equity (ROE) of -82.77%, return on capital employed of -366.33%, an operating margin of 6.37%, a net profit margin of 8.25%.
Official website: www.globalp.com